Six weeks after Vanguard Health Systems completed a disappointing initial public offering, many of the investment banks that steered that deal have come out with 'buy' — or the equivalent 'outperform' or 'overweight' — ratings. That makes sense, since the stock (Ticker: VHS) is down 10 percent even from its haircut IPO level. Among the firms advocating that investors step in now and calling for the stock to rise above $20 are Barclays Capital ($22), Gleacher & Co. ($20), Ticonderoga Securities ($21), Robert W. Baird ($22), Lazard Capital Markets ($21) and JPMorgan ($22). Citigroup is the relative outlier: It has a price target of $19.
Aug 2, 2011 8:24 AM
Public offering to fund product development, commercialization
Jul 12, 2010 4:16 PM
Long-awaited move targets $2.5B raise; board approves $500M special dividend
May 7, 2010 8:26 AM
Discount retailer plans to return to stock market after going private in 2007 buyout
Aug 20, 2009 11:19 PM
Lawyer blog recaps '07 proxy fights, LP shares up on lumber prediction, First Acceptance income rise sends stock up 12 percent, and more...
Nov 12, 2007 9:31 AM
TheStreet.com worried about the prospects for the hospital industry, Genesco buyout back on track?, Nashville ranks highly again, and more...
Sep 3, 2007 11:18 PM
City's largest publicly traded company in "merger of equals" with New England-based drugstore chain, to retain major presence locally, but main office will be in Rhode Island
Nov 1, 2006 9:44 AM